Humacyte, Inc. financial data

Symbol
HUMA, HUMAW on Nasdaq
Location
2525 East North Carolina Highway 54, Durham, NC
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 248 % -44.9%
Quick Ratio 43.3 %
Debt-to-equity -3.16K % -178%
Return On Equity 854 % -27%
Return On Assets -27.9 % +75.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 187M shares +48.8%
Common Stock, Shares, Outstanding 159M shares +32.5%
Entity Public Float 453M USD +154%
Common Stock, Value, Issued 16K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 158M shares +32.6%
Weighted Average Number of Shares Outstanding, Diluted 158M shares +32.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 753K USD
Research and Development Expense 75.4M USD -14.5%
General and Administrative Expense 25.8M USD +9.8%
Costs and Expenses 25.1M USD -16.8%
Operating Income (Loss) -105M USD +6.31%
Nonoperating Income (Expense) 68.4M USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -37M USD +75.8%
Earnings Per Share, Basic 0 USD/shares +82.8%
Earnings Per Share, Diluted 0 USD/shares +82.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.5M USD -5.27%
Cash, Cash Equivalents, and Short-term Investments 80.4M USD -47.1%
Accounts Receivable, after Allowance for Credit Loss, Current 1.08M USD
Inventory, Net 18.4M USD
Assets, Current 41.4M USD +79.7%
Property, Plant and Equipment, Net 19.9M USD -18.1%
Operating Lease, Right-of-Use Asset 0 USD
Other Assets, Noncurrent 672K USD -47.8%
Assets 91.5M USD -20.3%
Accounts Payable, Current 9.58M USD +38.7%
Employee-related Liabilities, Current 6.19M USD -2.33%
Accrued Liabilities, Current 10.3M USD -7.95%
Liabilities, Current 25.6M USD +22.2%
Deferred Income Tax Liabilities, Net 1.16M USD -23.4%
Operating Lease, Liability, Noncurrent 500K USD -16.7%
Other Liabilities, Noncurrent 520K USD -62.1%
Liabilities 96.3M USD -46.1%
Retained Earnings (Accumulated Deficit) -702M USD -5.56%
Stockholders' Equity Attributable to Parent -4.75M USD +92.5%
Liabilities and Equity 91.5M USD -20.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.6M USD -4.59%
Net Cash Provided by (Used in) Financing Activities 46.7M USD -25.6%
Net Cash Provided by (Used in) Investing Activities -228K USD +41.7%
Common Stock, Shares Authorized 350M shares +40%
Common Stock, Shares, Issued 159M shares +32.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17.9M USD -48.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.8M USD -72%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 183M USD +20.6%
Deferred Tax Assets, Gross 184M USD +20.1%
Operating Lease, Liability 0 USD
Depreciation 5.14M USD -0.72%
Payments to Acquire Property, Plant, and Equipment 228K USD -41.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37M USD +75.8%
Lessee, Operating Lease, Liability, to be Paid 784K USD -11.8%
Property, Plant and Equipment, Gross 59.9M USD +0.89%
Operating Lease, Liability, Current 57K USD +9.62%
Lessee, Operating Lease, Liability, to be Paid, Year Two 105K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 105K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -106%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 205K USD -20.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 105K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 97.9M USD +21.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 105K USD 0%
Additional Paid in Capital 697M USD +16%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.16M USD -23.4%
Share-based Payment Arrangement, Expense 9.13M USD +56%
Interest Expense 6.72M USD +3.85%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%